Siegfried Value Stock - Dividend - Research Selection
Market price: 727,50 CHF
Siegfried Holding AG Fundamental data and company key figures of the share
|Annual reports in CHF|
|Net operating cash flow||114.767.000|
|Free cash flow||46.005.000|
|Liabilities & Shareholders equity||1.242.280.000|
|Diluted shares outstanding||4.181.610|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||3.116.289.024,00 USD|
|Indices||STOXX EUROPE 600|
|Raw Data Source||IFRS in Millionen CHF|
Description of the company
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling liquid dosage forms. It offers contract development and manufacturing services, including process and chemical development, analytical development, pilot manufacturing and scale up, and commercial manufacturing. The company also provides APIs and controlled substances focusing on anesthetics, pain/addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.